PAA 2.63% 19.5¢ pharmaust limited

Ann: PharmAust to Evaluate Monepantel on COVID-19, page-152

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,641 Posts.
    lightbulb Created with Sketch. 580
    News Announcement: (Not official.....YET)

    PHARMAUST PAA/ASX, is Pleased to announce, Preliminary studies in the effect of Monepantel on the Covid19 Virus, Confirms “extraordinary” results, in killing the Virus very Quickly.
    Compared To Ivermectin (24 hour effect and irradiation in 48 Hours)
    MPL Monepantel showed signs of effect within 12 Hours....and inniahlation of the virus within 36 Hours.
    Due to Human Safety approval, Pharmaust now converges with the Oxford, to trial Monepantel on Humans, in “replacement” of Ivermectin trials.

    Just getting us hopefulls prepared.......@adreamer
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.